President Donald Trump’s Day One executive order rescinding Biden-era Medicare and Medicaid price innovation programs signals sweeping changes to the drug and treatment pricing agency within the ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Robert F. Kennedy Jr. (RFK Jr.) has been confirmed by the Senate as secretary of the Department of Health and Human Services (HHS). In this ...

Medicare spent $14.4 billion on Ozempic ... Ozempic, which the US Food and Drug Administration has approved to treat diabetes, and Wegovy, which is approved for weight loss and the prevention ...

In a statement released last week, the Centers for Medicare and Medicaid Services said that lowering the cost of prescription drugs is a top priority for the Trump administration. CMS added that ...

We now have a glimpse behind the curtain of how Medicare arrives at so-called maximum fair prices of prescription drugs it ...

Big drug maker Gilead expects to take a billion-dollar hit this year via drug-pricing provisions in the Inflation Reduction ...

Popular weight loss drugs like ... been added to Medicare’s list of medications that will be negotiated directly between the government and drug manufacturers, the Biden administration said ...

If Robert F. Kennedy Jr. and the Trump administration want to make America healthy again, they should let Medicare cover ...

Together with the first 10 drugs that the Biden administration targeted for its Medicare Drug Price Negotiation Program last year, the medications make up a third of prescription drug spending in ...